Centiva Capital, LP Illumina, Inc. Call Options Transaction History

Centiva Capital, LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$105.28 - $135.9 $2.13 Million - $2.75 Million	20,200 New	20,200 $2.63 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $265,845 - $341,160	1,500 New	1,500 $286,000
Q1 2020 May 15, 2020	BUY	$209.2 - $335.53 $2.32 Million - $3.72 Million	11,100 Added 1009.09%	12,200 $3.33 Million
Q4 2019 Feb 14, 2020	SELL	$288.29 - $335.49 $778,383 - $905,823	-2,700 Reduced 71.05%	1,100 $364,000
Q2 2019 Aug 13, 2019	BUY	$300.59 - $368.15 $1.05 Million - $1.29 Million	3,500 Added 1166.67%	3,800 $1.4 Million
Q1 2019 May 14, 2019	SELL	$272.57 - $321.18 $2.37 Million - $2.79 Million	-8,700 Reduced 96.67%	300 $93,000
Q4 2018 Feb 13, 2019	SELL	$272.46 - $366.54 $272,460 - $366,540	-1,000 Reduced 10.0%	9,000 $2.7 Million
Q2 2018 Aug 03, 2018	BUY	$228.17 - $292.07 $2.28 Million - $2.92 Million	10,000 New	10,000 $2.79 Million

897

138M

1.01M

1.33M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.